Vaccine News and Research

Latest Vaccine News and Research

New malaria-transmitting mosquitoes: an interview with Jennifer Stevenson, Research Fellow at the London School of Hygiene & Tropical Medicine

In the area in which we carried out the study, which was in the western Kenyan highlands, the main mosquitoes that have been confirmed to transmit malaria are the females of Anopheles gambiae sensu stricto, Anopheles arabiensis and Anopheles funestus.

28 Sep 2012

Paper provides overview on preventing invasive cervical cancer

Researchers at Moffitt Cancer Center and colleagues at the University of South Florida and The Ohio State University have published a paper in the September issue of Cancer Epidemiology, Biomarkers & Prevention that provides an overview on preventing invasive cervical cancer.

28 Sep 2012

Global Strategy for Women's and Children's Health receives $20 billion in new money

The Global Strategy for Women's and Children's Health has received about $20 billion in new money, according to a new report from The Partnership for Maternal, Newborn & Child Health (PMNCH).

28 Sep 2012

Study finds major risk factors for HIV among U.S. Armed Forces personnel during DADT era

Same-sex partners and inconsistent condom use were among the major risk factors for HIV infection among U.S. Navy and Marines personnel during the "Don't Ask, Don't Tell" (DADT) era, reports a study in the October 1 issue of JAIDS: Journal of Acquired Immune Deficiency Syndromes.

27 Sep 2012

Easy steps to protect against spread of influenza

Flu season is here and Concentra is sharing some easy steps to protect against the spread of influenza, including seasonal flu vaccines available at all Concentra locations across the country. Concentra is a subsidiary of Humana Inc., one of the nation's leading health and well-being companies

27 Sep 2012

NCI-funded sequencing project aims to identify genetic links to colorectal cancer

Uncovering colon cancer's genetic roots is the focus of a new $13 million, four-year, National Cancer Institute-funded project at Fred Hutchinson Cancer Research Center. Ulrike (Riki) Peters, Ph.D., M.P.H., a member of the Hutchinson Center's Public Health Sciences Division, will lead the effort. She and her colleagues will use next-generation sequencing, a technique that captures entire genome sequences, to identify genetic links to colorectal cancer.

27 Sep 2012

Researchers characterize brain's immune response to infiltrating metastases

Brain metastases are common secondary complications of other types of cancer, particularly lung, breast and skin cancer. The body's own immune response in the brain is rendered powerless in the fight against these metastases by inflammatory reactions. Researchers at the MedUni Vienna have now, for the first time, precisely characterised the brain's immune response to infiltrating metastases. This could pave the way to the development of new, less aggressive treatment options.

26 Sep 2012

PsiOxus initiates ColoAd1 phase I/II trial in metastatic solid tumours

PsiOxus Therapeutics, Ltd. has treated the first patient in its phase I/II clinical trial of ColoAd1for the treatment of metastatic solid tumours.

26 Sep 2012

Viewpoints: The 'real story' of Ryan at AARP; 'Get thee to an emergency room'

The headlines this weekend were all about the boos Paul Ryan elicited on Friday when he addressed the AARP, the self-styled seniors' lobby. The herd of independent media minds missed the real story, which is that the Republican Vice Presidential nominee went into the heart of the entitlement culture, told some hard truths, and even won applause for doing so.

26 Sep 2012

IVAC at Johns Hopkins announces grant recipients of World Pneumonia Day Advocacy Program

The International Vaccine Access Center (IVAC) at the Johns Hopkins Bloomberg School of Public Health (JHSPH) announced today recipients of the 2012 Small Grants for World Pneumonia Day Advocacy Program.

25 Sep 2012

UC Medicine nurses to administer free flu shots to licensed taxicab drivers at O'Hare Midway

As part of an initiative to vaccinate some of Chicago's most vulnerable populations, University of Chicago Medicine nurses will administer free flu shots to licensed taxicab drivers at O'Hare International Airport on Tuesday, Sept. 25, and at Midway International Airport the following Tuesday, Oct. 2. Up to 1,000 cabbies could be vaccinated over the two days.

25 Sep 2012

NanoBio to present data from preclinical studies at 8th Annual International RSV Symposium

NanoBio Corporation announced today it will present data from three preclinical studies at the 8th Annual International Respiratory Syncytial Virus (RSV) Symposium taking place from Sept. 27-30 in Santa Fe, N.M.

25 Sep 2012

Simple survey can effectively identify women with ovarian cancer symptoms

A simple three-question paper-and-pencil survey, given to women in the doctor's office in less than two minutes, can effectively identify those who are experiencing symptoms that may indicate ovarian cancer, according to a study by researchers at Fred Hutchinson Cancer Research Center.

24 Sep 2012

Newly discovered Eilat virus harmless and potentially valuable

A mosquito sample collected three decades ago in Israel's Negev Desert has yielded an unexpected discovery: a previously unknown virus that's closely related to some of the world's most dangerous mosquito-borne pathogens but, curiously, incapable of infecting non-insect hosts.

24 Sep 2012

Transmitted HIV strains may have evolutionary advantage, suggest scientists

A new study has found that even though HIV diversifies widely within infected individuals over time, the virus strains that ultimately are passed on through heterosexual transmission often resemble the strain of virus that originally infected the transmitting partner.

24 Sep 2012

Cholera vaccine stockpiles could help save lives in future outbreaks

In a post in the Bill & Melinda Gates Foundation's "Impatient Optimists" blog, Helen Matzger, a program officer in new vaccine delivery at the foundation, writes about outbreaks of cholera in Haiti, Sierra Leone, Guinea, and other areas, and says creating stockpiles of a recently WHO-approved cholera vaccine could help save lives in the future.

21 Sep 2012

Biovest seeks EMA approval for BiovaxID to treat non-Hodgkin's lymphoma

Biovest International, Inc., a majority-owned subsidiary of Accentia Biopharmaceuticals, Inc., today reported milestone achievements advancing BiovaxID, Biovest's personalized cancer vaccine for the treatment of non-Hodgkin's lymphoma, including a recently conducted regulatory meeting with the European Medicines Agency (EMA) and the appointment of a key contributor to the Human Genome Project to its Scientific Advisory Board.

21 Sep 2012

'Greater commitment' needed to fight NTDs

In a guest post on USAID's "IMPACT Blog," Rachel Cohen, regional executive director of DNDi North America, writes, "The United States government and its country partners should be commended for the tremendous achievements in the fight against neglected tropical diseases (NTDs) as part of the U.S. Agency for International Development (USAID) NTD Program" and the National Institutes of Health.

20 Sep 2012

BMJ examines emergence of China as 'major new player' in global vaccine production

"The Chinese drug industry is on the verge of getting the green light to manufacture the Japanese encephalitis vaccine for the developing world, an event that will signal the emergence of a major new player in global vaccines," BMJ reports.

20 Sep 2012

Bill Gates describes how 'catalytic philanthropy' can help bring vaccines, medicines to untouched markets

In an essay adapted for Forbes magazine from a speech given at the Forbes 400 Summit on Philanthropy in June, Bill Gates, co-chair of the Bill & Melinda Gates Foundation, discusses how "innovations for the poor suffer from ... market limitations" and his idea of "catalytic philanthropy." Gates writes, "The market is not going to place huge bets on research when there are no buyers for a breakthrough. This explains why we have no vaccine for malaria today, even though a million people die from it every year."

20 Sep 2012

Vaccine News and Research

Latest Vaccine News and Research

New malaria-transmitting mosquitoes: an interview with Jennifer Stevenson, Research Fellow at the London School of Hygiene & Tropical Medicine

Paper provides overview on preventing invasive cervical cancer

Global Strategy for Women's and Children's Health receives $20 billion in new money

Study finds major risk factors for HIV among U.S. Armed Forces personnel during DADT era

Easy steps to protect against spread of influenza

NCI-funded sequencing project aims to identify genetic links to colorectal cancer

Researchers characterize brain's immune response to infiltrating metastases

PsiOxus initiates ColoAd1 phase I/II trial in metastatic solid tumours

Viewpoints: The 'real story' of Ryan at AARP; 'Get thee to an emergency room'

IVAC at Johns Hopkins announces grant recipients of World Pneumonia Day Advocacy Program

UC Medicine nurses to administer free flu shots to licensed taxicab drivers at O'Hare Midway

NanoBio to present data from preclinical studies at 8th Annual International RSV Symposium

Simple survey can effectively identify women with ovarian cancer symptoms

Newly discovered Eilat virus harmless and potentially valuable

Transmitted HIV strains may have evolutionary advantage, suggest scientists

Cholera vaccine stockpiles could help save lives in future outbreaks

Biovest seeks EMA approval for BiovaxID to treat non-Hodgkin's lymphoma

'Greater commitment' needed to fight NTDs

BMJ examines emergence of China as 'major new player' in global vaccine production

Bill Gates describes how 'catalytic philanthropy' can help bring vaccines, medicines to untouched markets

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Vaccine News and Research

Latest Vaccine News and Research

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in